VivoSim Labs, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from VivoSim Labs, Inc.'s yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, is 1.7 times its market value (net cash). Higher than 94% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
1/3 · 2/3Sales grew in 1 of the last 3 years; profit grew in 2 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 65%
Sales fell 65% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-65% / -64%In 3 years sales changed by -65% while total assets changed by -64%. Both moved at about the same pace.
Balance-sheet strength
Debt Due Cover Ratio
-24.2×Operating cash was negative last year, while some debt falls due within a year.
Lower than 59% of Healthcare companies in United States.
Cash Cushion Ratio
1.7× cashCash, after subtracting all debt, is 1.7 times its market value (net cash).
Higher than 94% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
VivoSim Labs, Inc. made a loss over the last year. VivoSim Labs, Inc. owes $1.61 for every $1 it owns. VivoSim Labs, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Mar 2026.
P/E ratio
LossVivoSim Labs, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-1.13VivoSim Labs, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$3 MThe total market value of all of VivoSim Labs, Inc.'s shares at today's price (share price × number of shares), smaller than 96% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
NegativeVivoSim Labs, Inc.'s net worth is negative ($2 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Return on equity (ROE)
-343.1%VivoSim Labs, Inc. lost 343.1% of its shareholders' money over the last year, lower than 90% of Healthcare companies in United States.
Owes vs Owns
1.61×VivoSim Labs, Inc. owes $1.61 for every $1 it owns, so it owes more than it owns, higher than 95% of Healthcare companies in United States.
Dividend yield
NoneVivoSim Labs, Inc. does not currently pay a dividend.
Revenue growth
-9%Revenue fell 9% in the year to Mar 2026, and shrank 29% a year on average over 3 years.
Profit growth
LossVivoSim Labs, Inc. made a loss in each of the last two years.
Profit margin
-10567.2%VivoSim Labs, Inc. lost $10567 for every $100 of revenue.
Interest cover
Not coveredVivoSim Labs, Inc.'s operating profit did not cover its interest costs in the year to Mar 2026.
Cash vs debt
Net cashVivoSim Labs, Inc. held $5 M more cash than debt (net cash) at Mar 2026.
Questions
What is VivoSim Labs, Inc.'s return on equity?
VivoSim Labs, Inc. lost 343.1% of its shareholders' money over the last year, lower than 90% of Healthcare companies in United States.
How much does VivoSim Labs, Inc. owe compared with what it owns?
VivoSim Labs, Inc. owes $1.61 for every $1 it owns, so it owes more than it owns, higher than 95% of Healthcare companies in United States.
Does VivoSim Labs, Inc. pay a dividend?
No. VivoSim Labs, Inc. does not currently pay a dividend.
Is VivoSim Labs, Inc.'s revenue growing?
Revenue fell 9% in the year to Mar 2026, and shrank 29% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.